Advertisment

Understanding Atypical Teratoid Rhabdoid Tumor (AT/RT): Diagnosis and Care

author-image
Ethan Sulliva
New Update
NULL

Understanding Atypical Teratoid Rhabdoid Tumor (AT/RT): Diagnosis and Care

Advertisment

An Overview of Atypical Teratoid Rhabdoid Tumor (AT/RT)

Advertisment

Atypical teratoid rhabdoid tumor (AT/RT) is an extremely rare and fast-growing cancer that primarily affects young children. This aggressive form of cancer, which develops in the central nervous system, has been a subject of extensive research to improve its diagnosis and treatment outcomes. AT/RT, an embryonal tumor, typically occurs in very young children and necessitates specialized care for its management.

The Diagnosis of AT/RT

Dr. Susan McGovern explains that the diagnosis of AT/RT is a complex process. The initial identification of this tumor often involves imaging techniques. However, the use of radiology resources exposes children to potentially harmful radiation. To mitigate this risk, modern medicine prefers diagnostic imaging techniques that do not involve the use of ionizing radiation, such as ultrasound and magnetic resonance imaging. These techniques are safer and are preferred for pediatric patients.

Advertisment

Genomics and AT/RT

Research has made significant progress in understanding the genomic landscape of most types of childhood cancer, including AT/RT. Genomic studies have shown correlations between the molecular characteristics of childhood cancers and their tissue cell of origin. Structural variations, translocations, and mutations in genes involved in normal development play a crucial role in childhood cancers. The contribution of germline mutations to childhood cancer etiology is being advanced by whole genome and exome sequencing. Such groundbreaking research into the genomic aspects of AT/RT is paving the way for more precise and effective treatments.

Clinical Trials and New Treatments

Advertisment

MD Anderson researchers are leading the way in conducting clinical trials to test new treatments for rare cancers like AT/RT. These trials are crucial in improving our understanding of this rare cancer and developing more effective treatment strategies. The identification of genomically defined subsets of patients within histologies has led to early clinical translation and therapeutic direction.

Importance of Multidisciplinary Care

Dr. Susan McGovern emphasizes the importance of multidisciplinary care for patients with AT/RT. This approach involves the collaborative efforts of a team of healthcare professionals from diverse fields to ensure comprehensive care. The multidisciplinary team typically includes oncologists, radiologists, nurses, and other healthcare professionals. Their collaborative efforts are crucial in managing the complex needs of AT/RT patients and improving their treatment outcomes.

Advertisment

The Rising Incidence and Declining Death Rates

The overall cancer incidence rate in children and adolescents has been increasing since 1975. However, there is a silver lining to this grim statistic. Death rates from these cancers, including AT/RT, are on a continual decline. This trend suggests an improvement in the diagnosis and treatment of these cancers.

Conclusion

Atypical teratoid rhabdoid tumor is a rare and aggressive form of cancer that primarily affects young children. Despite its rarity, significant progress has been made in understanding its genomic landscape, leading to the development of more effective treatments. The importance of multidisciplinary care for patients with AT/RT cannot be overstated. There is much to be hopeful for, as research continues to advance and death rates continue to decline. Nevertheless, the fight against this rare cancer continues, with the ultimate goal of improving the quality of life and survival rates for young AT/RT patients.

Advertisment
Chat with Dr. Medriva !